← Back
Data updated: Mar 10, 2026
LUMICELL
OncologyGastroenterology
LUMICELL is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include LUMISIGHT.
2024
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 94%
1 drugs Phase 3: 1 Phase 2: 2 Phase 1: 3
Gastroenterology 6%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-04-17
- Latest
- 2024-04-17
- Applications
- 1